The use of thresholds of higher than 13.7 IU/mL for TPO-Ab or higher than 6.6 IU/mL for TG-Ab yielded the best sensitivity and specificity for differentiating GBS from CIDP. This evidence concerns the gene TG and Guillain-Barre syndrome.